1. Home
  2. CYTH vs BWEN Comparison

CYTH vs BWEN Comparison

Compare CYTH & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • BWEN
  • Stock Information
  • Founded
  • CYTH 1990
  • BWEN N/A
  • Country
  • CYTH United States
  • BWEN United States
  • Employees
  • CYTH N/A
  • BWEN 444
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • CYTH Health Care
  • BWEN Industrials
  • Exchange
  • CYTH Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • CYTH 31.9M
  • BWEN 34.5M
  • IPO Year
  • CYTH N/A
  • BWEN N/A
  • Fundamental
  • Price
  • CYTH $0.91
  • BWEN $1.56
  • Analyst Decision
  • CYTH Buy
  • BWEN Strong Buy
  • Analyst Count
  • CYTH 3
  • BWEN 3
  • Target Price
  • CYTH $0.95
  • BWEN $5.17
  • AVG Volume (30 Days)
  • CYTH 4.5M
  • BWEN 93.4K
  • Earning Date
  • CYTH 03-17-2025
  • BWEN 03-05-2025
  • Dividend Yield
  • CYTH N/A
  • BWEN N/A
  • EPS Growth
  • CYTH N/A
  • BWEN N/A
  • EPS
  • CYTH N/A
  • BWEN 0.14
  • Revenue
  • CYTH $870,725.00
  • BWEN $156,169,000.00
  • Revenue This Year
  • CYTH N/A
  • BWEN N/A
  • Revenue Next Year
  • CYTH $24.49
  • BWEN $25.42
  • P/E Ratio
  • CYTH N/A
  • BWEN $11.21
  • Revenue Growth
  • CYTH N/A
  • BWEN N/A
  • 52 Week Low
  • CYTH $0.55
  • BWEN $1.52
  • 52 Week High
  • CYTH $1.79
  • BWEN $4.65
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 53.59
  • BWEN 35.80
  • Support Level
  • CYTH $0.85
  • BWEN $1.66
  • Resistance Level
  • CYTH $1.45
  • BWEN $1.75
  • Average True Range (ATR)
  • CYTH 0.13
  • BWEN 0.08
  • MACD
  • CYTH -0.00
  • BWEN -0.01
  • Stochastic Oscillator
  • CYTH 22.83
  • BWEN 3.57

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through three operating segments namely Heavy Fabrications, Gearing and Industrial Solutions.

Share on Social Networks: